Skip to main content
logo
Prostatype Genomics AB (publ) (STO:PROGEN)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.1470
+0.0005 (0.34%)
Sep 4, 2026, 5:29 PM CET

Prostatype Genomics AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.010.591.923.730.682.51
Revenue Growth
70.71%-69.03%-48.55%445.83%-72.78%-16.56%
Gross Profit
-16.94-20.2-20.44-16.1-12.81-5.98
Operating Income
-37.46-38.94-40.85-39.25-28.69-15.55
Net Income
-37.9-44.5-41.05-41.44-29.09-15.63
Earnings Per Share
--1.32-29.10-512.68-1597.92-1105.51
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
0.399.079.422.6811.4920.33
Total Debt
-5.30.0711.670.871.27
Net Cash (Debt)
0.393.779.35-8.9910.6219.06
Net Cash Growth
-89.60%-59.71%---44.28%32.42%
Net Cash Per Share
-0.116.63-111.17583.531348.32

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-20.9-23.8-44.71-29.14-27.69-16.08
Capital Expenditures
-0.06-0.26-0.29-0.08--
Free Cash Flow
-20.96-24.06-44.99-29.21-27.69-16.08
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
------238.34%
Operating Margin
-3694.18%-6555.22%-2130.03%-1052.76%-4200.44%-619.54%
Pretax Margin
-3737.97%-7492.09%-2140.30%-1111.45%-4258.71%-622.79%
Profit Margin
-3737.97%-7492.09%-2140.30%-1111.45%-4258.71%-622.79%
FCF Margin
-2066.86%-4050.34%-2345.88%-783.61%-4054.61%-640.66%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
81.2029.8938.803.0470.9553.75